| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/18/2009 | CN101370786A Substituted imidazoles and their use as pesticides |
| 02/18/2009 | CN101370497A Combination therapy with PARP inhibitors |
| 02/18/2009 | CN101367793A Amino-quinazoline derivative with antineoplastic activity and its salts |
| 02/18/2009 | CN101367792A Benzotriazole light stabilizer containing hindered amine group |
| 02/18/2009 | CN101367791A Insecticidal active compound |
| 02/18/2009 | CN101367768A N-(2-pyrimidine oxygen based)benzyl sulfonylamines compounds, preparation method and uses thereof |
| 02/18/2009 | CN101366714A Acetylene derivatives having mGluR5 antagonistic activity |
| 02/18/2009 | CN100462363C Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/17/2009 | US7491831 PPAR active compounds |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491737 Heterarylpiperidine modulators of chemokine receptor activity |
| 02/17/2009 | US7491735 e.g. N-(3-{4-[(4-Bromo-phenyl)-(3-chloro-benzyl)-amino]-piperidin-1-yl}-butyl)-3,5-dichloro-isonicotinamide; viricide, antiinflammation agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV) |
| 02/17/2009 | US7491727 Arylpiperazinyl compounds |
| 02/17/2009 | US7491724 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | US7491717 1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 02/17/2009 | US7491713 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2356087C Methods and compositions for treatment of cell proliferative disorders |
| 02/17/2009 | CA2316474C Stabilizer mixtures |
| 02/12/2009 | WO2009020454A1 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
| 02/12/2009 | WO2009020323A2 Process for preparing voriconazole |
| 02/12/2009 | WO2009020198A1 Aniline derivative having anti-dna virus activity |
| 02/12/2009 | WO2009020191A1 Tetrazoyloxime derivative and plant disease control agent |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
| 02/12/2009 | WO2009019656A1 Pyridyl derivatives, their preparation and use |
| 02/12/2009 | WO2009019506A1 Heterocyclyc sulfonamides having edg-1 antagonistic activity |
| 02/12/2009 | WO2009019472A1 1, 2, 4 -triazole derivatives as serotonergic modulators |
| 02/12/2009 | WO2009019469A2 Pyrrolidines as catalyst compounds |
| 02/12/2009 | WO2009019274A1 Substituted phenylenediamines as inhibitors of the interaction between mdm2 and p53 |
| 02/12/2009 | WO2009019163A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | WO2009019149A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 02/12/2009 | WO2009019099A1 Tetrasubstituted pyrimidine derivatives for controlling phytopathogenic fungi |
| 02/12/2009 | WO2009018925A1 Herbicide triazolylpyridine ketones |
| 02/12/2009 | WO2009018657A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2009018656A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2008155594A3 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 02/12/2009 | WO2008107480A8 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 02/12/2009 | US20090042949 Indoles Useful in the Treatment of Inflammation |
| 02/12/2009 | US20090042947 Pharmacologically active compounds containing sulfur |
| 02/12/2009 | US20090042944 Potassium Channel Inhibitors |
| 02/12/2009 | US20090042938 Chemical Compounds |
| 02/12/2009 | US20090042935 Novel iv formulation of tipifarnib |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042919 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 02/12/2009 | US20090042918 Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3 |
| 02/12/2009 | US20090042910 Quinoline derivatives for treating cancer |
| 02/12/2009 | US20090042903 For treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; obesity; N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-C-phenyl-methanesulfonamide; C-(4-chloro-phenyl)-N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-methanesulfonamide |
| 02/12/2009 | US20090042902 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics |
| 02/12/2009 | US20090042901 Agent for prevention/therapy of disease caused by keratinocyte growth |
| 02/12/2009 | US20090042900 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/12/2009 | US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | US20090042891 6-(3-Fluorophenyl)-5-pyridin-4-ylpyrazin-2-amine, used in the treatment of asthma, chronic obstructive pulmonary disorder, fibrosis, emphysema, allergies, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, inflammatory bowel disease or autoimmune diseases |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | US20090042886 Benzamide Inhibitors of the P2X7 Receptor |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042881 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/12/2009 | US20090042880 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042867 Compounds for the treatment of alzheimer's disease |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042864 Pyrazole compounds |
| 02/12/2009 | US20090042855 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME |
| 02/12/2009 | US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
| 02/12/2009 | US20090042852 Novel Pyridine Compounds |
| 02/12/2009 | US20090042841 Novel heterocyclic derivatives as m-glu5 antagonists |
| 02/12/2009 | US20090041723 useful in the production of a library of pyrazole derivatives for biological screening; Hepatitis C virus (HCV); ease of crystallization, yield, stability, solubility, hygroscopicity and flowability of the resulting bulk drug |
| 02/12/2009 | US20090041721 Arylalkoxyl hepatitis c virus protease inhibitors |
| 02/12/2009 | US20090041720 Heteroaryl substituted thiazoles |
| 02/12/2009 | CA2695621A1 Pyridine carboxamide orexin receptor antagonists |
| 02/12/2009 | CA2695437A1 Aminopyrazole amide derivative |
| 02/12/2009 | CA2695331A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 02/12/2009 | CA2695325A1 Herbicide triazolylpyridine ketones |
| 02/12/2009 | CA2695211A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | CA2693997A1 Viral polymerase inhibitors |
| 02/12/2009 | CA2693495A1 Viral polymerase inhibitors |
| 02/11/2009 | EP2022789A1 Process for the preparation of a gastric acid secretion inhibitor |
| 02/11/2009 | EP2022785A1 Alkynylpyrimidines as Tie2 kinase inhibitors |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | EP2021338A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof |
| 02/11/2009 | EP2021337A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 02/11/2009 | EP2021336A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 02/11/2009 | EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 02/11/2009 | EP2021334A1 Synthesis and uses of pyroglutamic acid derivatives |
| 02/11/2009 | EP2021330A2 Benzimidazole modulators of vr1 |
| 02/11/2009 | EP2021329A1 Inhibitors of c-fms kinase |
| 02/11/2009 | EP2021324A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
| 02/11/2009 | EP1893604B1 Method for producing n,n-bis(pyridin-2-yl-methyl)-1,1-bis(pyridin-2-yl)-1-aminoalkane compounds and metal complex salts containing these compounds |
| 02/11/2009 | EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/11/2009 | CN101365695A Quinazoline derivatives as anticancer agents |
| 02/11/2009 | CN101365693A Selected CGRP antagonists, methods for the production thereof and their use as medicaments |